Immix Biopharma Inc (IMMX)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $657.09M
Last updated: Nov 17, 2026 at 4:33 PM ET
Immix Biopharma Inc (IMMX) Stock Chart
Immix Biopharma (IMMX) has a latest price of $7.20 on Nov 17, 2026, 52.3% below its 52-week high of $15.10. Its price rose 71.0% over the past 12 months. The month-end price rose 112.2% over the 3 years through Oct 2026, a compound annual rate of 28.5%.
Price Chart
From Dec 2021 to Oct 2026, its highest month-end close was $14.03 in Aug 2026 and its lowest $1.00 in Oct 2022, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart IMMX with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for IMMX.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 45.4%, and over 6 months it fell 18.7%.
| Period | Change |
|---|---|
| 1 month | -12.4% |
| 3 months | -45.4% |
| 6 months | -18.7% |
| 12 months | +71.0% |
| 12 months, with dividends | +71.0% |
| Period | Change | Per year |
|---|---|---|
| 3 years | +112.2% | +28.5% |
Price by Year
Its best calendar year was 2023, when the price rose 202.2%, and its weakest was 2024, when it fell 68.2%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $7.68 | +46.8% |
| 2025 | $5.23 | +137.7% |
| 2024 | $2.20 | -68.2% |
| 2023 | $6.92 | +202.2% |
| 2022 | $2.29 | -35.7% |
Trading Range
The price is 24.7% below its 50-day average of $9.57 and 25.2% below its 200-day average of $9.63.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $7.20 | |
| 52-week high | $15.10 | -52.3% |
| 52-week low | $3.78 | +90.5% |
| 50-day average | $9.57 | -24.7% |
| 200-day average | $9.63 | -25.2% |
Price Risk
Over 3 years, its largest fall from a peak was 81.6%.
| Measure | Value |
|---|---|
| 1-year beta | 1.80 |
| Largest fall, 1 year | -50.2% |
| Largest fall, 3 years | -81.6% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About IMMX
What is IMMX's 1-year price change?
Immix Biopharma's price rose 71.0% over the past 12 months. With dividends included, the 12-month total return was 71.0%.
How has IMMX stock done over the long term?
Immix Biopharma's month-end price rose 112.2% over the 3 years through Oct 2026, a compound annual rate of 28.5%. These figures leave out dividends.
What is IMMX's 52-week high and low?
Immix Biopharma's 52-week high is $15.10 and its 52-week low is $3.78. Its latest price of $7.20 on Nov 17, 2026 is 52.3% below the high.
What is IMMX's beta?
Immix Biopharma's 1-year beta against the S&P 500 is 1.80, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 50.2%.
Is the IMMX chart free?
Yes. Advanced Charting for IMMX is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
IMMX pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Competitors